Early prostate cancer often causes no pain, urinary changes, or other noticeable symptoms. A person can feel healthy while the disease is developing, making age and personal risk important reasons to discuss screening with a doctor.
On September 1, 2026, the Urology Care Foundation launched its PROstate of Mind campaign, encouraging people with a prostate to have that conversation before symptoms appear.
The foundation is the official charitable arm of the American Urological Association (AUA). For average-risk patients, the campaign cites AUA advice to begin screening discussions between ages 45 and 50.
A prostate-specific antigen (PSA) blood test can help identify who needs further assessment. The decision to test involves weighing potential benefits against possible harms, with family history and overall health helping guide the choice.
Why Prostate Cancer Can Remain Unnoticed
The explanation partly comes down to anatomy. The prostate surrounds the urethra, the tube carrying urine from the bladder out of the body. Many prostate cancers begin in the gland’s outer region, away from that tube.
As Prostate Cancer UK explains, a tumor growing there may initially leave urine flow undisturbed. A familiar daily routine, including an uneventful trip to the bathroom, offers little information about whether cancer is present.
The scale of the disease gives September’s campaign particular relevance. In its awareness month announcement, the American Cancer Society estimated 333,830 new prostate cancer diagnoses and 36,320 deaths in the United States during 2026. Those are projected annual totals, covering cancers diagnosed at different stages.
The @AmericanCancer estimates that approximately 333,830 new cases of prostate cancer will be diagnosed in the United States in 2026. At Hattiesburg Clinic, a simple blood test is used to screen for prostate cancer without invasive procedures. Learn more: https://t.co/LEAkDhjenE pic.twitter.com/FlNbpEPG4f
— Hattiesburg Clinic (@HburgClinic) September 1, 2026
When to Start the Screening Conversation
Screening means checking for possible cancer in someone without symptoms. Professional organizations use different starting ages, so advice should reflect the guideline being followed and the individual’s risk.
The American Cancer Society’s recommendations provide the following starting points for a discussion in the United States:
Begin discussion at
Who the recommendation covers
Age 50
Men at average risk who are expected to live at least another 10 years
Age 45
African American men, or men whose father or brother was diagnosed before age 65
Age 40
Men with more than one first-degree relative diagnosed at an early age
A relative’s age at diagnosis can be useful information. Ask family members about prostate cancer before the appointment, and bring any previous PSA results or inherited cancer-risk test results.
General health also matters. Someone with a serious illness that substantially limits life expectancy may gain little benefit from screening for a cancer that could grow slowly.
The choice deserves a conversation about personal circumstances, including preferences about further testing.
Access to a clinician can influence whether that conversation happens at all. A recent AccessNewsWire profile highlighted efforts to reduce some of the practical barriers that can make people postpone specialist care.
Dr. Nathan Starke, a Houston urologist and fellowship-trained andrologist, has emphasized giving patients more direct opportunities to raise questions about urological and men’s health concerns.
Urinary Changes Still Deserve Attention
Getting up repeatedly at night or noticing a weaker stream can be easy to accommodate gradually. A person may start planning journeys around bathroom stops before mentioning the change to a clinician.
Difficulty starting urination, increased frequency, and blood in urine or semen should be discussed with a doctor. According to the American Cancer Society’s symptom guidance, urinary problems are much more commonly caused by benign prostatic hyperplasia, a noncancerous enlargement of the prostate.
Persistent back or hip pain and unexplained weight loss can occur with advanced prostate cancer, alongside several other conditions. Assessment helps establish the cause; symptoms alone cannot identify a diagnosis.
Severe back pain accompanied by new leg weakness or loss of bladder or bowel control requires emergency care. Such symptoms can indicate spinal cord compression, where pressure on nerves needs rapid treatment.
What Happens Around a PSA Test
PSA is a protein produced by normal and cancerous prostate cells. The blood test measures its concentration, giving clinicians one piece of information about the prostate.
Reading the Result in Context
An elevated PSA level can occur with cancer, benign enlargement or prostate inflammation. Recent ejaculation can temporarily raise it, while medicines such as finasteride can lower the measured level.
Tell the clinician about medications and recent urinary infections, and follow the clinic’s preparation instructions. The ACS explains that several factors affect PSA, making context essential when interpreting a result.
No single cutoff reliably separates everyone with cancer from everyone without it. A result within the laboratory’s usual range cannot exclude every prostate cancer, and a raised result does not establish a diagnosis.
Following up an Elevated Result
For someone without symptoms, a doctor may repeat an abnormal PSA test after six to eight weeks to check whether the finding persists, according to the National Cancer Institute.
The timing and next steps depend on the clinical circumstances.
Further assessment may involve an examination, additional blood or urine tests, or prostate MRI. Imaging can help locate suspicious areas and inform decisions about biopsy. A biopsy collects small tissue samples for microscopic examination to establish whether cancer is present.
If cancer is found, the biopsy can also help estimate how likely it is to grow and spread. The result helps guide subsequent discussions about monitoring and treatment.
Before leaving an appointment, ask who will explain the results and when. A clear follow-up arrangement makes an uncertain result easier to manage.
Finding Cancer Can Lead to Different Care Plans
View this post on Instagram
Screening can detect prostate cancer earlier and reduce the risk of dying from it for some men. Potential downsides include false alarms, biopsy complications, and overdiagnosis, meaning detection of a cancer that would never have caused problems during a person’s lifetime.
The ACS discusses those benefits and limitations as part of an informed screening decision.
For suitable patients with low-risk cancer, active surveillance provides scheduled monitoring while treatment is deferred. Johns Hopkins Medicine describes a process involving PSA tests, examinations, MRI, and repeat biopsies, with treatment considered if findings indicate progression.
At Johns Hopkins, for example, PSA testing typically occurs every three to six months. Repeat biopsies may be scheduled every one to five years, depending on findings. Monitoring schedules vary between patients and centers.
Surveillance requires keeping appointments and reviewing changes with the care team. It can help patients avoid or postpone treatment-related effects on urinary and sexual function while preserving the opportunity for treatment when appropriate.
Put Prostate Health on the Appointment List
@aprokodoctorProstate cancer is quietly taking our men. Emeka, don’t let “I’m strong” be your last words. Know all the signs through the full video on YouTube (link is in my bio)♬ original sound – Aproko Doctor
September offers a useful prompt to ask about personal risk, gather family history and discuss whether PSA testing is appropriate. Ask how often to return if the result is reassuring, and what follow-up would accompany an abnormal finding.
Anyone noticing symptoms should arrange assessment promptly. Early prostate cancer can develop quietly; a screening conversation can begin while a person feels entirely well.
